Target: Tumors

A Smart Bomb Against Cancer in Mice Must Still Prove Itself in Humans.

If headlines could cure deadly diseases, then everyone would have rejoiced last week. Across the U.S., newspapers heralded the development by scientists from Bristol-Myers Squibb of a "smart bomb," or "magic bullet," against cancer. The weapon, a type of protein called a monoclonal antibody combined with an anticancer drug, has wiped out a wide variety of tumors in laboratory mice.

Before people get too excited, though, they should know that researchers have attacked cancer with many kinds of monoclonal antibodies for 15 years and that success in mice has spawned only limited benefit in people. Back in the 1980s, Wall Street...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!